Financials
Financial year 2025
Worth noting
- More debts than assets in the latest financial year.
Revenue
€ 56.4 million
▲ 41% vs 2024
Profit
Growing€ 174,639
▲ 564% vs 2024
Debts
High€ 13.4 million
▲ 159% vs 2024
PI PHARMA from Sint-Pieters-Leeuw, company number BE0883315652, closed financial year 2025 with a result of € 174,639 after tax. For that financial year PI PHARMA recorded revenue of € 56.4 million and equity of € -161,750. Compared with financial year 2024, the result moved from € 26,306 to € 174,639. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.
What happened at PI PHARMA?
What happened at PI PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Nikka Management BV stepped down as director. NBB
- Jordan Chir stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 174,639 (▲ 564% vs 2024). Source: NBB ↗
- Jordan Chir became a director. NBB
- LMDC GmbH stepped down as director. NBB
- Nikka Management BV became a director. NBB
- LMDC GmbH became a director. NBB
- New establishment in Anderlecht. KBO
In short
From € 1.7 million loss in 2021 to € 174,639 profit in 2025.
Paid € 1.8 million in corporate taxes since 2021.
Best year ever: 2025, with € 174,639 profit.
Paid out € 380,000 in dividends to the owners in total.
A new publication or filing at PI PHARMA? We notify you, reason included.
Follow PI PHARMANeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
since 2025 · until 2031
since 2025 · until 2031
LMDC GmbH
Director · represented by Libor Matyasek
Also active at: ECOPHARMASUPPLY DISTRIBUTION, IMPEXECO, ECO.PHARMA.SUPPLY +1 more
since 2025 · until 2025
Establishments
Establishment units
Physical locations of this company
Bergensesteenweg 709
1600 Sint-Pieters-Leeuw
Marie Curiesquare 50
1070 Anderlecht
Active since 1 January 2011
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 39 companies are registered at this address.
SURUBI
€ 15,011 gross margin · 2025
IMMO PRIMERA
€ 324,993 gross margin · 2025
IBURU
€ 132,863 gross margin · 2025
Bedrijvencentrum Zennevallei
€ 217,792 gross margin · 2025
GALLÉ
€ -5,836 gross margin · 2025
+34 more
Details
- Company number
- 0883.315.652
- VAT number
- BE 0883.315.652
- Registered office
- Bergensesteenweg 709, 1600 Sint-Pieters-Leeuw
- Names & denominations
- PI PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 5 September 2006
- Peppol
- Active · Active since 6 Jan 2026
- Activities · NACE
Groothandel in farmaceutische producten
Groothandel in farmaceutische en medische artikelen
Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren